Inogen Valuation
| INGN Stock | USD 7.08 0.20 2.91% |
At this time, the firm appears to be undervalued. Inogen Inc retains a regular Real Value of $7.45 per share. The prevalent price of the firm is $7.08. Our model calculates the value of Inogen Inc from evaluating the firm fundamentals such as Return On Asset of -0.0621, current valuation of 81.78 M, and Return On Equity of -0.13 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Inogen's price fluctuation is somewhat reliable at this time. Calculation of the real value of Inogen Inc is based on 3 months time horizon. Increasing Inogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Inogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Inogen Stock. However, Inogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.08 | Real 7.45 | Hype 7.13 | Naive 7.28 |
The intrinsic value of Inogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Inogen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Inogen Inc helps investors to forecast how Inogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inogen more accurately as focusing exclusively on Inogen's fundamentals will not take into account other important factors: Inogen Total Value Analysis
Inogen Inc is currently forecasted to have valuation of 81.78 M with market capitalization of 186.78 M, debt of 19.41 M, and cash on hands of 223.62 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Inogen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
81.78 M | 186.78 M | 19.41 M | 223.62 M |
Inogen Investor Information
About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. Inogen Inc recorded a loss per share of 1.0. The entity had not issued any dividends in recent years. Based on the analysis of Inogen's profitability, liquidity, and operating efficiency, Inogen Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Inogen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Inogen has an asset utilization ratio of 113.34 percent. This suggests that the Company is making $1.13 for each dollar of assets. An increasing asset utilization means that Inogen Inc is more efficient with each dollar of assets it utilizes for everyday operations.Inogen Ownership Allocation
Inogen Inc has a total of 27.15 Million outstanding shares. The majority of Inogen Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inogen to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inogen Inc. Please pay attention to any change in the institutional holdings of Inogen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Inogen Profitability Analysis
The company reported the previous year's revenue of 335.7 M. Net Loss for the year was (35.89 M) with profit before overhead, payroll, taxes, and interest of 155.32 M.About Inogen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Inogen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Inogen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Inogen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Inogen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inogen. We calculate exposure to Inogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Inogen's related companies.Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. Inogen operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1021 people.
Inogen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 23.7 M | |
| Quarterly Earnings Growth Y O Y | 0.873 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.